Gain Therapeutics, Inc. Contracts & Agreements
40 Contracts & Agreements
- Business Finance (18 contracts)
- Business Operations (4)
- Human Resources (15)
- Uncategorized (3)
- Separation Agreement, dated June 27, 2024, between the Company and Matthias Alder (Filed With SEC on November 14, 2024)
- Distribution Agreement, dated September 6, 2024, by and between Gain Therapeutics, Inc. and Oppenheimer & Co. Inc (Filed With SEC on September 6, 2024)
- Form of Underwriter Warrant (Filed With SEC on June 14, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on June 14, 2024)
- Underwriting Agreement, dated June 13, 2024, by and between Gain Therapeutics, Inc. and Titan Partners Group, LLC, as Underwriter (Filed With SEC on June 14, 2024)
- Employment Agreement, by and between the Company and Gene Mack, effective as of April 8, 2024 (Filed With SEC on April 8, 2024)
- Description of Securities (Filed With SEC on March 26, 2024)
- Warrant Agent Agreement by and between Gain Therapeutics, Inc. and Pacific Stock Transfer Company (Filed With SEC on November 22, 2023)
- Underwriting Agreement, dated November 21, 2023, by and between Gain Therapeutics, Inc. and Newbridge Securities Corporation, as Underwriter (Filed With SEC on November 22, 2023)
- Form of Warrant (Filed With SEC on November 22, 2023)
- Form of Private Warrant (Filed With SEC on November 22, 2023)
- Form of Underwriters Warrant (Filed With SEC on November 22, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on November 22, 2023)
- Form of Placement Agent Warrant (Filed With SEC on November 22, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on November 22, 2023)
- Form of Indemnification Agreement for Officers and Directors (Filed With SEC on November 14, 2023)
- Form of Indemnification Agreement for Officers and Directors (Filed With SEC on August 10, 2023)
- Separation Agreement and Release, by and between GT Gain Therapeutics SA and Salvatore Calabrese, dated April 27, 2023 (Filed With SEC on April 28, 2023)
- Employment Agreement, by and between the Company and Evan Ballantyne, dated April 10, 2023 (Filed With SEC on April 12, 2023)
- Amended and Restated Employment Agreement, by and between the Company and Matthias Alder, dated September 20, 2022 (Filed With SEC on September 20, 2022)
- Transition Agreement, by and between the Company and Eric Richman, dated September 19, 2022 (Filed With SEC on September 20, 2022)
- Executive Employment Agreement, effective as of October 15, 2021, between Gain Therapeutics, Inc. and Matthias Alder (Filed With SEC on March 25, 2022)
- Description of Securities (Filed With SEC on March 25, 2022)
- Form of Stock Option Agreement under the 2021 Inducement Plan (Filed With SEC on December 28, 2021)
- Gain Therapeutics, Inc. 2021 Inducement Equity Incentive Plan (Filed With SEC on December 28, 2021)
- Executive Employment Agreement, effective as of October 15, 2021, between Gain Therapeutics, Inc. and Matthias Alder (Filed With SEC on November 12, 2021)
- Underwriting Agreement, effective as of March 17, 2021, by and among BTIG, LLC and Oppenheimer & Co. Inc. as representatives of the several underwriters named therein and the... (Filed With SEC on March 22, 2021)
- Form of Underwriting Agreement (Filed With SEC on March 15, 2021)
- Form of Indemnification Agreement for Officers and Directors(b) (Filed With SEC on March 10, 2021)
- Form of Specimen common stock certificate (Filed With SEC on March 10, 2021)
- 2020 Omnibus Incentive Plan(b) (Filed With SEC on March 10, 2021)
- Investors Rights Agreement, dated as of July 20, 2020, by and among Gain Therapeutics, Inc. and certain holders of its capital stock (Filed With SEC on February 19, 2021)
- Form of Placement Agent Warrant (Filed With SEC on February 19, 2021)
- Form of Exchange Agreement (Filed With SEC on February 19, 2021)
- Executive Employment Agreement, effective as of November 2, 2020, between Gain Therapeutics, Inc. and Salvatore Calabrese(b) (Filed With SEC on February 19, 2021)
- Consulting Agreement effective as of September 1, 2019, between GT Gain Therapeutics S.A. and Sal Calabrese (Filed With SEC on February 19, 2021)
- Consulting Agreement effective as of September 1, 2019, between GT Gain Therapeutics S.A. and Sal Calabrese (Filed With SEC on February 19, 2021)
- Executive Employment Agreement, effective as of August 13, 2020, between Gain Therapeutics, Inc. and Manolo Bellotto(b) (Filed With SEC on February 19, 2021)
- Executive Employment Agreement, effective as of July 20, 2020, between Gain Therapeutics, Inc. and Eric I. Richman(b) (Filed With SEC on February 19, 2021)
- Minoryx Agreement between Minoryx Therapeutics, S.L. and GT Gain Therapeutics SA (Filed With SEC on February 19, 2021)
